Show simple item record

dc.contributor.authorDamoiseaux, Jan
dc.contributor.authorAndrade, Luis E. [UNIFESP]
dc.contributor.authorFritzler, Marvin J.
dc.contributor.authorShoenfeld, Yehuda
dc.date.accessioned2016-01-24T14:40:33Z
dc.date.available2016-01-24T14:40:33Z
dc.date.issued2015-06-01
dc.identifierhttp://dx.doi.org/10.1016/j.autrev.2015.01.017
dc.identifier.citationAutoimmunity Reviews. Amsterdam: Elsevier B.V., v. 14, n. 6, p. 555-563, 2015.
dc.identifier.issn1568-9972
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/39121
dc.description.abstractAt the 12th International Workshop on Autoantibodies and Autoimmunity (IWAA), organized in August 2014 in São Paulo, Brazil, more than 300 autoimmunologists gathered to discuss the status of many novel autoantibodies in clinical practice, and to envisage additional value of autoantibodies in terms of prediction, prognosis and prevention of autoimmune diseases. Two separate workshops were dedicated to standardization and harmonization of autoantibody testing and nomenclature: International Autoantibody Standardization (IAS) and International Consensus on ANA Patterns (ICAP). It was apparent to all in attendance that the discovery and elucidation of novel autoantibodies did not slow down, but that multiple challenges lay ahead of us in order to apply these discoveries to effective and efficient clinical practice. Importantly, this requires optimal bidirectional communication between clinicians and laboratory specialists, as well as close collaboration with the diagnostic industry. This paper is a report on the 12th IWAA in combination with a review of the recent developments in the field of autoantibodies. (C) 2015 Elsevier B.V. All rights reserved.en
dc.format.extent555-563
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofAutoimmunity Reviews
dc.rightsAcesso restrito
dc.subjectAutoandbodiesen
dc.subjectHarmonizationen
dc.subjectStandardizationen
dc.subjectDiagnosisen
dc.titleAutoantibodies 2015: From diagnbstic biomarkers toward prediction, prognosis and preventionen
dc.typeResenha
dc.rights.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.contributor.institutionMaastricht Univ
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionUniv Calgary
dc.contributor.institutionSheba Med Ctr
dc.contributor.institutionFleury Med & Hlth Labs
dc.description.affiliationMaastricht Univ, Med Ctr, Cent Diagnost Lab, NL-6229 HX Maastricht, Netherlands
dc.description.affiliationUniversidade Federal de São Paulo, Div Rheumatol, São Paulo, Brazil
dc.description.affiliationUniv Calgary, Cumming Sch Med, Calgary, AB, Canada
dc.description.affiliationSheba Med Ctr, Zabludowicz Ctr Autoimmune Dis, Tel Hashomer, Israel
dc.description.affiliationFleury Med & Hlth Labs, Div Immunol, São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Div Rheumatol, São Paulo, Brazil
dc.identifier.doi10.1016/j.autrev.2015.01.017
dc.description.sourceWeb of Science
dc.identifier.wosWOS:000353731800011


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record